Who Exports Vincristine from India — 253 Suppliers Behind a $2.0M Market
India's vincristine export market is supplied by 253 active exporters who collectively shipped $2.0M across 1,311 shipments. VENUS REMEDIES LIMITED leads with a 24.4% market share, followed by NAPROD LIFE SCIENCES PRIVATE LIMITED and MEDWISE OVERSEAS PRIVATE LIMITED. The top 5 suppliers together control 50.4% of total export value, reflecting a moderately competitive market structure.
Top Vincristine Exporters from India — Ranked by Export Value
VENUS REMEDIES LIMITED is the leading vincristine exporter from India, holding a 24.4% share of the $2.0M market across 1,311 shipments from 253 exporters. The top 5 suppliers — VENUS REMEDIES LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, NV REMEDIES PRIVATE LIMITED — collectively control 50.4% of total export value, indicating a moderately concentrated market. Individual shares are: VENUS REMEDIES LIMITED (24.4%), NAPROD LIFE SCIENCES PRIVATE LIMITED (11.2%), MEDWISE OVERSEAS PRIVATE LIMITED (5.5%), UNITED BIOTECH PRIVATE LIMITED (4.7%), NV REMEDIES PRIVATE LIMITED (4.7%).
Top Vincristine Exporters from India
Ranked by export value · 253 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | VENUS REMEDIES LIMITED VINCRISTINE SULPHATE INJECTIONM U.S.P (1VINCRIMED 2 MGVINCRISTINE SULPHATE INJECTIONM U.S.P(1M | $494.4K | 15 | 24.4% |
| 2 | NAPROD LIFE SCIENCES PRIVATE LIMITED VINCRISTINE SULFATE FOR INJECTION USP 1MVINCRISTINE SULFATE FOR INJECTION USP 1MGVINCRISTINE SULFATE FOR INJECTION | $227.7K | 5 | 11.2% |
| 3 | MEDWISE OVERSEAS PRIVATE LIMITED VINCRIMED 2 MGVINCRIMED 1 MGVINCRISTINE SULFATE FOR INJECTION | $111.5K | 3 | 5.5% |
| 4 | UNITED BIOTECH PRIVATE LIMITED VINCRISTINE SULPHATE INJECTION USP 1MG/MUNICRISTIN,B.NO.UCIC5A4 M.03/2025, E.02/202711000 VIALS OF VINCRISTINE SULPHATE INJE | $95.4K | 12 | 4.7% |
| 5 | NV REMEDIES PRIVATE LIMITED VINCRISTINE SULPHATE INJECTION U.S.P (1M | $94.6K | 3 | 4.7% |
| 6 | INTAS PHARMACEUTICALS LIMITED VINCRISTINE SULFATE FOR INJECTION | $94.3K | 2 | 4.6% |
| 7 | NEON LABORATORIES LIMITED VINCRISTINE SULFATE FOR INJECTION USP 2MG/VIAL-ONVINC-2VINCRISTINE SULPHATE INJECTION USP 1MG/ML-2ML- ONVINC-2 | $75.0K | 4 | 3.7% |
| 8 | SWASTHYA HEALTHCARE PRIVATE LIMITED | $55.9K | 2 | 2.8% |
| 9 | KWALITY PHARMACEUTICALS LIMITED VINCRISTINE SULFATE FOR INJECTION | $55.2K | 4 | 2.7% |
| 10 | BELCO PHARMA VINCRISTINE SULPHATE INJECTION USP 1MG/MUNICRISTIN,B.NO.UCIC5A4 M.03/2025, E.02/202711000 VIALS OF VINCRISTINE SULPHATE INJE | $51.8K | 1 | 2.6% |
| 11 | MISSIONPHARMA LOGISTICS INDIA PRIVATE LIMITED | $40.3K | 2 | 2.0% |
| 12 | CELON LABORATORIES PRIVATE LIMITED | $39.4K | 9 | 1.9% |
| 13 | BETA DRUGS LIMITED VINCRIMED 2 MGVINCRIMED 1 MGVINCRIMED 2 (VINCRISTINE SULFATE INJECTI | $29.8K | 6 | 1.5% |
| 14 | KHANDELWAL LABORATORIES PRIVATE LIMITED | $27.3K | 2 | 1.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Vincristine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Venus Remedies Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Belco Pharma | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Kwality Pharmaceuticals Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| United Biotech Private Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Khandelwal Laboratories Private Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Celon Laboratories Private Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Naprod Life Sciences Private Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
| Intas Pharmaceuticals Limited | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certified as per CDSCO list dated November 2025. |
TransData Nexus reviewed the regulatory standing of 8 leading Vincristine exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Vincristine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is home to Genome Valley, a prominent life sciences hub. This cluster encompasses over 200 pharmaceutical companies specializing in the production of active pharmaceutical ingredients (APIs) and bulk drugs. The region's infrastructure and supportive policies have attracted significant investments, making it a key player in the global pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat hosts approximately 3,332 pharmaceutical units, contributing significantly to India's pharmaceutical exports. Companies in this region are known for their expertise in developing and manufacturing a wide range of finished dosage forms, including tablets, capsules, and injectables.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for Indian pharmaceuticals. Maharashtra leads the country with 40 pharmaceutical clusters, facilitating the export of pharmaceutical products to over 200 countries. The region's proximity to major ports and well-established logistics infrastructure enhance its role in global pharmaceutical trade.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. The region hosts 555 pharmaceutical units, attracting numerous companies to set up manufacturing facilities. This cluster contributes substantially to the domestic supply of pharmaceuticals and serves as a manufacturing base for exports.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers to ensure consistent quality and regulatory adherence.
- Leverage Cluster Specializations: Align sourcing strategies with the specific strengths of each cluster, such as bulk drug production in Hyderabad or formulations in Ahmedabad-Vadodara.
- Monitor Regulatory Changes: Stay informed about policy shifts and tax incentives in various regions to optimize sourcing decisions and cost structures.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Vincristine exporters from India
Venus Remedies Limited — Venus Remedies announces promoter group merger
Venus Remedies Limited disclosed a merger between its promoter group entities, Sunev Pharma Solutions Private Limited and Spine Software Systems Private Limited. This internal restructuring consolidates the promoter group's holdings without altering the company's control structure. - IMPACT: No direct impact on Vincristine exports; internal restructuring maintains existing operations.
Impact: No direct impact on Vincristine exports; internal restructuring maintains existing operations.
Venus Remedies Limited — Venus Remedies secures Vincristine approval in Thailand
Venus Remedies received regulatory approval from the Thai Food and Drug Administration for Vincristine 1 mg/1 ml, enhancing its oncology portfolio in the ASEAN region. - IMPACT: Potential increase in Vincristine exports to Thailand, strengthening market presence.
Impact: Potential increase in Vincristine exports to Thailand, strengthening market presence.
Venus Remedies Limited — Venus Remedies secures Vietnam approvals for key drugs
Venus Remedies obtained marketing authorizations in Vietnam for Methotrexate, Cefuroxime, and Irinotecan, expanding its ASEAN export portfolio. - IMPACT: While not directly related to Vincristine, these approvals may enhance overall export capabilities and market reach.
Impact: While not directly related to Vincristine, these approvals may enhance overall export capabilities and market reach.
Common Questions — Vincristine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which vincristine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, VENUS REMEDIES LIMITED leads with 93 recorded shipments worth $494.4K. NAPROD LIFE SCIENCES PRIVATE LIMITED (15 shipments) and MEDWISE OVERSEAS PRIVATE LIMITED (11 shipments) are also established high-volume exporters.
Q How many vincristine manufacturers are there in India?
India has 253 active vincristine exporters with a combined export market of $2.0M across 1,311 shipments to 113 countries. The top 5 suppliers hold 50.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for vincristine from India?
Average FOB unit price: $1.52 per unit, ranging from $0.01 to $173.97. Average shipment value: $1.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 253 verified Indian exporters of Vincristine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,311 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 113 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,311 Verified Shipments
253 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists